Bone Biologics Corporation (BBLGW)Burlington, United States | NasdaqCM
20.00 USD
Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:23 p.m. EDT
High-risk speculative play with deteriorating fundamentals and extreme balance sheet leverage. Recent volatility is narrowing the technical upside despite the price bouncing from lows, while negative earnings and massive combined short-term liabilities (implied by a current ratio of 13.84 vs negative cash flows) signal severe distress. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.400921 |
| MSTL | 0.405171 |
| AutoETS | 0.405651 |
| AutoTheta | 0.406817 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.23 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.555 |
| Excess Kurtosis | -0.57 |
| Attribute | Value |
|---|---|
| Beta | 0.37 |
| Website | https://www.bonebiologics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.009900987 |
| Address1 | 2 Burlington Woods Drive |
| Address2 | Suite 100 |
| All Time High | 95.04 |
| All Time Low | 0.002 |
| Ask | 0.0 |
| Ask Size | 0 |
| Average Daily Volume10 Day | 270 |
| Average Daily Volume3 Month | 845 |
| Average Volume | 845 |
| Average Volume10Days | 270 |
| Beta | 0.367 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 2.995 |
| City | Burlington |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 20.0 |
| Current Ratio | 13.847 |
| Custom Price Alert Confidence | HIGH |
| Day High | 20.0 |
| Day Low | 20.0 |
| Display Name | Bone Biologics |
| Ebitda Margins | 0.0 |
| Eps Trailing Twelve Months | -0.144 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 24.5848 |
| Fifty Day Average Change | -4.5848007 |
| Fifty Day Average Change Percent | -0.18648924 |
| Fifty Two Week Change Percent | -0.9900987 |
| Fifty Two Week High | 35.95 |
| Fifty Two Week High Change | -15.950001 |
| Fifty Two Week High Change Percent | -0.4436718 |
| Fifty Two Week Low | 8.3 |
| Fifty Two Week Low Change | 11.7 |
| Fifty Two Week Low Change Percent | 1.4096385 |
| Fifty Two Week Range | 8.3 - 35.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,634,131,800,000 |
| Float Shares | 1,794,578 |
| Free Cashflow | -1,650,181 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 2 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,021-10-13 |
| Language | en-US |
| Long Business Summary | Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts. |
| Long Name | Bone Biologics Corporation |
| Market | us_market |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_99330767 |
| Net Income To Common | -3,108,991 |
| Open | 9.97 |
| Operating Cashflow | -2,691,150 |
| Operating Margins | 0.0 |
| Phone | 781 552 4452 |
| Previous Close | 20.0 |
| Price Hint | 2 |
| Price To Book | 6.6777964 |
| Profit Margins | 0.0 |
| Quick Ratio | 12.767 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 20.0 |
| Regular Market Day Low | 20.0 |
| Regular Market Day Range | 20.0 - 20.0 |
| Regular Market Open | 9.97 |
| Regular Market Previous Close | 20.0 |
| Regular Market Price | 20.0 |
| Regular Market Time | 1,776,268,841 |
| Regular Market Volume | 284 |
| Return On Assets | -0.41871 |
| Return On Equity | -0.70171 |
| Sand P52 Week Change | 0.38150132 |
| Sector | |
| Sector Key | |
| Short Name | BONE BIOLOGICS CORP C/WTS (TO P |
| Source Interval | 15 |
| State | MA |
| Symbol | BBLGW |
| Total Cash | 5,334,322 |
| Total Cash Per Share | 2.971 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.144 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.83145 |
| Two Hundred Day Average Change | 3.1685505 |
| Two Hundred Day Average Change Percent | 0.1882518 |
| Type Disp | Equity |
| Volume | 284 |
| Website | https://www.bonebiologics.com |
| Zip | 1,803 |